|Articles|October 1, 2011
- BioPharm International-10-01-2011
- Volume 24
- Issue 10
BioPharm International, October 2011 Issue (PDF)
Examining the Outsourcing Relationship
Advertisement
Articles in this issue
about 14 years ago
Education and Training in Biopharmaceutical Developmentabout 14 years ago
Trends in Biologics Outsourcingabout 14 years ago
Survey Examines Trends in the Outsourcing Relationshipabout 14 years ago
Volatile Markets Take a Toll on Life-Sciences Initial Public Offeringsabout 14 years ago
Contract Services Spending: Who's Spending What, and Where?about 14 years ago
Global Health Challenges Spur Vaccine Developmentabout 14 years ago
Preparing for the Last Warabout 14 years ago
Perspectives in MicroRNA Therapeuticsabout 14 years ago
How to Choose the Right CMONewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
5
